New drugs in non-Hodgkin's lymphoma

被引:9
作者
Arbuck, SG
Sorensen, JM
Christian, MC
Ho, P
Pluda, JM
Cheson, BD
机构
关键词
bryostatin; chemotherapy; cladrabine; docetaxel; fludarabine; 506U; irinotecan; lymphoma; 9-aminocamptothecin; paclitaxel; suramin; topotecan;
D O I
10.1023/A:1008290925515
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
While novel agents designed to target molecular abnormalities involved in lymphoma pathogenesis are most likely to improve current therapeutic results, cytotoxic therapy remains the mainstay of therapy. Several new chemotherapy agents, including purine antimetabolites, taxanes, camptothecins, suramin, and protein kinase C inhibitors, are discussed. Other issues important in lymphoma drug development, including the limited patient population available for evaluation of investigational agents, are also considered.
引用
收藏
页码:119 / 128
页数:10
相关论文
共 99 条
[41]  
KURTZBERG J, 1996, P AN M AM SOC CLIN, V15, pA2022
[42]  
LAMBE CU, 1995, CANCER RES, V55, P3352
[43]   A PILOT-STUDY OF SURAMIN IN THE TREATMENT OF PROGRESSIVE REFRACTORY FOLLICULAR LYMPHOMAS [J].
LAROCCA, RV ;
COOPER, MR ;
STEIN, CA ;
KOHLER, D ;
UHRICH, M ;
WEINBERGER, E ;
MYERS, CE .
ANNALS OF ONCOLOGY, 1992, 3 (07) :571-573
[44]  
Lebecq, 1996, P AN M AM SOC CLIN, V15, P476
[45]  
LEVINE BL, 1991, J IMMUNOL, V147, P3474
[46]  
LOKIEC F, 1995, CANCER CHEMOTH PHARM, V36, P79
[47]  
MAHONEY CW, 1990, J BIOL CHEM, V265, P5424
[48]   THE BCL-2 AND P53 ONCOPROTEINS CAN BE MODULATED BY BRYOSTATIN-1 AND DOLASTATINS IN HUMAN DIFFUSE LARGE-CELL LYMPHOMA [J].
MAKI, A ;
DIWAKARAN, H ;
REDMAN, B ;
ALASFAR, S ;
PETTIT, GR ;
MOHAMMAD, RM ;
ALKATIB, A .
ANTI-CANCER DRUGS, 1995, 6 (03) :392-397
[49]  
MALSPEIS L, 1990, SEMIN ONCOL, V17, P18
[50]   PHASE-I STUDY OF THE COMBINATION OF FLUDARABINE, MITOXANTRONE, AND DEXAMETHASONE IN LOW-GRADE LYMPHOMA [J].
MCLAUGHLIN, P ;
HAGEMEISTER, FB ;
SWAN, F ;
CABANILLAS, F ;
PATE, O ;
ROMAGUERA, JE ;
RODRIGUEZ, MA ;
REDMAN, JR ;
KEATING, M .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (03) :575-579